Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Moodys
QuintilesIMS
Cantor Fitzgerald
Healthtrust
Merck
McKinsey
Accenture
Covington
Mallinckrodt

Generated: August 17, 2017

DrugPatentWatch Database Preview

SUPPRELIN Drug Profile

« Back to Dashboard

Which patents cover Supprelin, and what generic Supprelin alternatives are available?

Supprelin is a drug marketed by Shire and Endo Pharm and is included in two NDAs. There is one patent protecting this drug.

The generic ingredient in SUPPRELIN is histrelin acetate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the histrelin acetate profile page.

Summary for Tradename: SUPPRELIN

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list11
Clinical Trials: see list1
Patent Applications: see list2,082
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SUPPRELIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-001Dec 24, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Endo Pharm
SUPPRELIN LA
histrelin acetate
IMPLANT;SUBCUTANEOUS022058-001May 3, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-002Dec 24, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-003Dec 24, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SUPPRELIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-001Dec 24, 1991► Subscribe► Subscribe
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-003Dec 24, 1991► Subscribe► Subscribe
Shire
SUPPRELIN
histrelin acetate
INJECTABLE;INJECTION019836-002Dec 24, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Chubb
Covington
Express Scripts
Boehringer Ingelheim
US Department of Justice
Johnson and Johnson
Cantor Fitzgerald
McKesson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot